C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2002
08/01/2002	WO2002059339A1 Process for producing cytochrome c
08/01/2002	WO2002059322A2 Compositions and methods relating to the daptomycin biosynthetic gene cluster
08/01/2002	WO2002059318A1 A humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof
08/01/2002	WO2002059312A2 Cell adhesion proteins
08/01/2002	WO2002059311A2 Colon cancer marker
08/01/2002	WO2002059310A2 Polynucleotides encoding cellular transporters and methods of use thereof
08/01/2002	WO2002059308A2 Method of diagnosing and treating cartilage disorders
08/01/2002	WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor
08/01/2002	WO2002059295A1 Novel serine protease mp493
08/01/2002	WO2002059293A2 Process and compositions for peptide, protein and peptidomimetic synthesis
08/01/2002	WO2002059290A2 A method for evolving a cell having desired phenotype and envolved cells
08/01/2002	WO2002059286A2 Adenylate cyclases
08/01/2002	WO2002059283A2 Nucleic acid modification enzymes
08/01/2002	WO2002059282A2 Adipocyte complement related protein zacrp13
08/01/2002	WO2002059281A2 High level cytokine production with enhanced cell viability
08/01/2002	WO2002059267A2 Constitutively desensitized g protein-coupled receptors
08/01/2002	WO2002059264A2 Specific human antibodies for selective cancer therapy
08/01/2002	WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/01/2002	WO2002059154A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/01/2002	WO2002059153A2 Anticoagulants and their uses
08/01/2002	WO2002059150A2 Materials and methods relating to protein aggregation in neurodegenerative disease
08/01/2002	WO2002059148A2 A method for identification, isolation and production of antigens to a specific pathogen
08/01/2002	WO2002058637A2 Compositions and methods for diagnosis of neuropsychiatric disorders
08/01/2002	WO2002058635A2 Nicotine immunogens and antibodies and uses thereof
08/01/2002	WO2002043651A3 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
08/01/2002	WO2002042480A3 Modified vaccinia ankara virus variant
08/01/2002	WO2002036761A9 Compositions and methods for the diagnosis of cancer
08/01/2002	WO2002020614A3 Endoglin-specific polypeptide, production and use thereof
08/01/2002	WO2002008285A3 Il-17 molecules and uses thereof
08/01/2002	WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same
08/01/2002	WO2001098453A3 Modified construct downstream of the initiation codon for recombinant protein overexpression
08/01/2002	WO2001096565A3 Binding agents: chimeric ligand/receptor proteins
08/01/2002	WO2001087925A3 Methods for refolding proteins containing free cysteine residues
08/01/2002	WO2001083527A3 Glucagon antagonists
08/01/2002	WO2001080633A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
08/01/2002	WO2001075110A3 Mucin-1 specific binding members and methods of use thereof
08/01/2002	WO2001072836A3 G-protein coupled receptors
08/01/2002	WO2001070955A3 Identification of essential genes in prokaryotes
08/01/2002	WO2001034808A9 Method of large-scale production and method of testing of the biological activity of a substance from soybean
08/01/2002	WO2001029072A9 P15paf cell cycle proteins associated with pcna, compositions and methods of use
08/01/2002	WO2001016368A9 In vitro transcription systems and uses
08/01/2002	WO2000077040A9 Human intracellular signaling molecules
08/01/2002	US20020104123 Viral amplification of recombinant messenger RNA in transgenic plants
08/01/2002	US20020104113 Nav2 channel gene-deficient non-human animals
08/01/2002	US20020103604 System and computer software products for comparative gene expression analysis
08/01/2002	US20020103358 Nucleotide sequences coding preferential polypeptide for use in tumor therapy
08/01/2002	US20020103345 Bispecific immunoglobulin-like antigen binding proteins and method of production
08/01/2002	US20020103343 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
08/01/2002	US20020103340 Rab proteins
08/01/2002	US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/01/2002	US20020103336 Cloning of chicken anemia dna
08/01/2002	US20020103125 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/01/2002	US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption
08/01/2002	US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods
08/01/2002	US20020103114 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia
08/01/2002	US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease
08/01/2002	US20020102730 Expression system for factor VIII
08/01/2002	US20020102723 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects
08/01/2002	US20020102711 Polypeptide for use in the treatment of cancer and immunological
08/01/2002	US20020102710 Polypeptide for use in the treatment of cancer, autoimmune diseases and inflammation
08/01/2002	US20020102701 licD1
08/01/2002	US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy
08/01/2002	US20020102658 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/01/2002	US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease
08/01/2002	US20020102656 Modulating the immune response
08/01/2002	US20020102655 Simultaneous expression of both the heterologous protein, including functional membrane proteins, and a means for compartmentalizing or sequestering of the protein
08/01/2002	US20020102653 DNA coding for human cell surface antigen
08/01/2002	US20020102651 Novel B7-4 molecules and uses therefor
08/01/2002	US20020102650 Generating preferential heterologous protein in culture; obtain cells, transform with expression vector containing heterologous protein, recover transformed cells, propagate, culture, express and recover heterologous proteins
08/01/2002	US20020102649 Human transport protein homologs
08/01/2002	US20020102647 Nucleotide sequences coding membrane protein for use in treatment of nervous system disorders and arthritis
08/01/2002	US20020102643 Dorsal tissue affecting factor and compositions
08/01/2002	US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging
08/01/2002	US20020102638 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases, genetic disorders and cancer
08/01/2002	US20020102619 Heparanase specific molecular probes and their use in research and medical applications
08/01/2002	US20020102618 Drosophila derived receptors of the steroid receptor superfamily
08/01/2002	US20020102604 Full-length human cDNAs encoding potentially secreted proteins
08/01/2002	US20020102569 Nucleotide sequences for use in the detection, classificataions, treatment and evaluation of cancer therapies
08/01/2002	US20020102560 Nucleotide sequences coding enzymatic polypeptide for use in treatment metastasis and tumors
08/01/2002	US20020102542 Polypeptide for use in the treatment of cancer, autoimmune and viral diseases
08/01/2002	US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof
08/01/2002	US20020102276 For diagnosis, therapy and prophylaxis of Neisseria meningitidis infection; vaccine
08/01/2002	US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/01/2002	US20020102269 Contacting a parental Helicobacter with molecule in biological sample, testing and comparing response to extracellular pH and sensitivity to acidity of parental strain to a strain deficient in UreI; selecting molecule
08/01/2002	US20020102268 For use in detecting apoptosis and testing candidate compounds for enhancing or inhibiting apoptosis
08/01/2002	US20020102263 Diagnosis and treatment of malignant neoplasms
08/01/2002	US20020102262 For prophhylaxis of Staphylococcus aureus infection
08/01/2002	US20020102254 For diagnostic and therapeutic uses in cancer
08/01/2002	DE10101962A1 DNA-Sequenz mit regulatorischen Bereichen zur Expression von Proteinen DNA sequence with regulatory regions for expression of proteins
08/01/2002	DE10101430A1 Lösliche cyclische Analoga Soluble cyclic analogues
08/01/2002	CA2792244A1 A method for identification, isolation and production of antigens to a specific pathogen
08/01/2002	CA2436091A1 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/01/2002	CA2435910A1 Oomycete ftsz-mt as a target for antimicrobial-specific biocides
08/01/2002	CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/01/2002	CA2435433A1 High level cytokine production with enhanced cell viability
08/01/2002	CA2435047A1 Constitutively desensitized g protein-coupled receptors
08/01/2002	CA2433227A1 Specific human antibodies for selective cancer therapy
08/01/2002	CA2432134A1 Adenylate cyclases
08/01/2002	CA2432096A1 Methods for preparing purified lipopeptides
08/01/2002	CA2431517A1 Polynucleotides encoding cellular transporters and methods of use thereof

1 ... 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 ... 1125